As such, the present study aimed to characterize the circulating immune cell subsets in both MCI and dementia stages of AD and to explore immunological associations with clinical parameters such as CSF analyses of Aβ and tau pathology, CSF markers for neurodegeneration and neuroinflammation, and different cognitive tests covering global cognition, memory, attention, and executive function. This evidence concerns the gene MAPT and Alzheimer disease.